Displaying drugs 14526 - 14550 of 14829 in total
Trichloroacetaldehyde
Experimental
Antimonous acid
Experimental
Methylphosphinic Acid
Experimental
Lactaldehyde
Experimental
PROPYL-1-PHOSPHATE
Experimental
Propyl Trihydrogen Diphosphate
Experimental
Ethyl Dihydrogen Diphosphate
Experimental
Dibromothymoquinone
At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. [PubChem]
Experimental
NRP409
NRP409 is a triiodothyronine (T3) hormone, being investigated by New River Pharmaceuticals as a treatment for patients with primary hypothyroidism.
Investigational
BNC105
Investigational
Dapansutrile
Dapansutrile is under investigation in clinical trial NCT01768975 (Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee).
Investigational
Cambinol
Cambinol is a beta-naphtol derivative that inhibits NAD-dependant deacetylases to reduce cell survival under stress. This activity is currently being investigated for its use as a cancer treatment.
Experimental
Lauroyl chloride
Experimental
Betaine aldehyde
Experimental
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol
Experimental
2,3-Dimethyl-1,4-naphthoquinone
Experimental
Acetyl chloride
Experimental
P-Hydroxybenzaldehyde
Experimental
1-Amino-1-Carbonyl Pentane
Experimental
Acetophenone
Experimental
Lawsone
Experimental
Displaying drugs 14526 - 14550 of 14829 in total